N/A
Completed N=120
Impact of COVID-19 on Marshallese Communities in the U.S.
Source: ClinicalTrials.gov NCT04474496 ↗Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcomePrimary: Personal Preventative Behaviors to Decrease Risk of COVID-19 Exposure — 114; 112; 114; 109 Participants
Summary
Marshallese adults in the U.S. will complete an online or telephone survey. This survey will collect data describing the impact of COVID-19 on Marshallese communities. Data collected will help describe: 1) risk exposure, 2) knowledge of preventive recommendations, 3) barriers and facilitators to implementing preventative recommendations, 4) barriers and facilitators to COVID-19 testing when appropriate, and 5) self-care behaviors during COVID-19. Participant inclusion criteria: 1) Self-reported Marshallese; 2) 18 years of age or older; 3) Live in the Continental U.S. or Hawaii.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Personal Preventative Behaviors to Decrease Risk of COVID-19 Exposure |
114; 112; 114; 109; 105; 113 | — |
| PRIMARY Workplace Preventative Actions to Decrease Risk of COVID-19 Exposure |
27; 23; 73; 41; 58; 59 | — |
| SECONDARY Effects of COVID-19 on General Health Status |
20; 74; 19; 6 | — |
| SECONDARY Effects of COVID-19 on Access to Healthcare Services |
20; 14; 20; 21; 53; 5 | — |
| SECONDARY Effects of COVID-19 on Dietary Habits |
25; 41; 30; 18; 5 | — |
| SECONDARY Effects of COVID-19 on Physical Activity Behaviors (Not Specifically for Exercise) |
27; 52; 35; 5 | — |
| SECONDARY Effects of COVID-19 on Physical Activity Behaviors (Specifically for Exercise) |
17; 56; 37; 9 | — |
| SECONDARY Effects of COVID-19 on Weight |
30; 26; 34; 26; 3 | — |
| SECONDARY Effects of COVID-19 on HbA1c (Glycated Hemoglobin) |
2; 5; 3; 3 | — |
| SECONDARY Barriers to Type 2 Diabetes Management Due to COVID-19 |
2; 1; 1; 3; 0; 9 | — |
| SECONDARY COVID-19 Screening |
9; 7; 45; 32; 27; 28 | — |
| SECONDARY COVID-19 Testing |
20; 1; 6; 54; 33; 9 | — |
| SECONDARY COVID-19 Vaccine Willingness/Hesitancy |
39; 25; 8; 9; 32 | — |
| SECONDARY Trusted Sources of COVID-19 Information |
12; 15; 1; 14; 4; 40 | — |
| SECONDARY Effects of COVID-19 on Housing |
3; 12; 4; 98; 1 | — |
| SECONDARY Effects of COVID-19 on Employment |
12; 13; 9; 27; 4; 23 | — |
| SECONDARY Effects of COVID-19 on Income |
3; 66; 43; 7 | — |
| SECONDARY Sources of Stress During COVID-19 |
75; 90; 75; 79; 61; 75 | — |
Eligibility Criteria
Inclusion Criteria
- Self-reported Marshallese
- 18 years of age or older
- Live in the Continental U.S. or Hawaii
Exclusion Criteria
- Does not meet inclusion criteria
Data sourced from ClinicalTrials.gov (NCT04474496). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.